Randomized, Modified, Double-Blind, Placebo-Controlled, Phase II, Dose-Ranging Study of the Safety and Immunogenicity of Single Dose ChimeriVax-WN02 Vaccine in Healthy Adults

Trial Profile

Randomized, Modified, Double-Blind, Placebo-Controlled, Phase II, Dose-Ranging Study of the Safety and Immunogenicity of Single Dose ChimeriVax-WN02 Vaccine in Healthy Adults

Completed
Phase of Trial: Phase II

Latest Information Update: 08 Apr 2015

At a glance

  • Drugs West Nile virus vaccine (Primary)
  • Indications West Nile virus infections
  • Focus Adverse reactions; Pharmacodynamics
  • Sponsors sanofi pasteur
  • Most Recent Events

    • 15 Feb 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 15 Feb 2011 Actual end date (Dec 2009) added as reported by ClinicalTrials.gov.
    • 04 Dec 2009 Planned end date changed from 1 Feb 2013 to 1 Feb 2011 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top